Wallace joined the fund as an associate in 2018 and is currently responsible for biopharmaceutical investments. Previously, she served as a financial services consultant at the Accenture Strategy group in London. Wallace studied Genetics at the University of York and completed the MPhil in Bioscience Enterprise at the University of Cambridge, where she was recognized and awarded as one of the highest performing graduate students. She is active as a guest lecturer and dissertation supervisor at the University of Cambridge, on both the MPhil in Therapeutic Sciences and MPhil in Bioscience Enterprise. Wallace is based in Amsterdam.